DSGN Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsDSGN Upcoming Earnings Report: What to Expect?
3M ago
Design Therapeutics reports Q1 EPS (20c), consensus (26c)
Premium
The Fly
Design Therapeutics reports Q1 EPS (20c), consensus (26c)
6M ago
Design Therapeutics upgraded to Overweight from Neutral at Piper Sandler
Premium
The Fly
Design Therapeutics upgraded to Overweight from Neutral at Piper Sandler
6M ago
Design Therapeutics reports Q4 EPS (21c), consensus (31c)
PremiumThe FlyDesign Therapeutics reports Q4 EPS (21c), consensus (31c)
8M ago
Design Therapeutics, Inc. (DSGN) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Design Therapeutics, Inc. (DSGN) Q4 Earnings Cheat Sheet
8M ago
Design Therapeutics cut to Neutral at Piper on limited near-term news flow
Premium
The Fly
Design Therapeutics cut to Neutral at Piper on limited near-term news flow
12M ago
Redfin upgraded, CSSE downgraded: Wall Street’s top analyst calls
PremiumThe FlyRedfin upgraded, CSSE downgraded: Wall Street’s top analyst calls
1y ago
Design Therapeutics downgraded to Market Perform at SVB Securities
Premium
The Fly
Design Therapeutics downgraded to Market Perform at SVB Securities
1y ago
Wedbush downgrades Design Therapeutics to Neutral, cuts price target to $6
Premium
The Fly
Wedbush downgrades Design Therapeutics to Neutral, cuts price target to $6
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100